GlobalPost: In these four countries, the TPP’s rules on generic drugs could kill people
“For its backers, including the White House, the world’s largest ever trade deal is a no-brainer. … But in four of them — Peru, Mexico, Malaysia, and Vietnam — the TPP may have a particular dark side. According to leaks of the still-under-wraps treaty text, the deal would block some of those nations’ poorest citizens from accessing life-saving, cutting-edge medicines known as ‘biologics’…” (Tegel, 10/8).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.